Kelly R McMahon1,2, Maya Harel-Sterling3, Michael Pizzi1, Louis Huynh4, Erin Hessey5, Michael Zappitelli6,7. 1. Department of Pediatrics, Division of Nephrology, Montreal Children's Hospital, McGill University Health Centre, Montreal, Quebec, Canada. 2. Faculty of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada. 3. Department of Pediatrics, Toronto Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. 4. Faculty of Health Sciences, Queen's University, Kingston, Ontario, Canada. 5. Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada. 6. Department of Pediatrics, Division of Nephrology, Toronto Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. michael.zappitelli@sickkids.ca. 7. Toronto Hospital for Sick Children, Peter Gilgan Centre For Research and Learning (PGCRL), 686 Bay Street, Child Health Evaluative Sciences, 6th floor, Room 6.9708, Toronto, Ontario, M5G 0A4, Canada. michael.zappitelli@sickkids.ca.
Abstract
BACKGROUND: Childhood cancer survivors treated with cisplatin, ifosfamide, or carboplatin are at risk for late kidney and blood pressure (BP) abnormalities. Few studies have comprehensively evaluated kidney outcomes and 24-h ambulatory BP monitoring (ABPM) in this population. We aimed to describe chemotherapy-associated acute kidney injury (AKI) and late kidney outcomes using standardized definitions. METHODS: This was a single-center longitudinal pilot study of 23 children who participated in a previous study during cisplatin, carboplatin, or ifosfamide treatment. Medical charts were reviewed retrospectively. Available patients were approached for a study visit for blood and urine collection, BP measurement, and ABPM. AKI is defined by serum creatinine (SCr) rise (Kidney Disease: Improving Global Outcomes definition [SCr-AKI]). Electrolyte-AKI is defined by hypokalemia, hypophosphatemia, or hypomagnesemia. Chronic kidney disease (CKD) is defined by estimated glomerular filtration rate < 90 mL/min/1.73 m2, albuminuria, or proteinuria. Electrolyte-CKD is defined by low serum electrolyte concentration or electrolyte supplementation. RESULTS: Median age at chemotherapy start was 8.3 years; 9/23 (39%) were boys. Fourteen out of 23 (61%) patients had SCr-AKI during therapy; all developed electrolyte-AKI. Median 5.7 years post-chemotherapy, 7/22 (32%) had CKD, 11/23 (48%) had electrolyte-CKD, and 2/20 (10%) had hypertension. Fifteen out of 23 patients (65%) had either CKD, electrolyte-CKD, or hypertension. In ten patients available for a study visit (median 4.9 years post-chemotherapy), 1/10 (10%) had hypertension by ABPM; none had masked or white coat hypertension. All ten had at least one kidney abnormality (CKD, electrolyte-CKD, office pre-hypertension, or abnormal ABPM). CONCLUSIONS: Using standardized outcome definitions, children treated with cisplatin, carboplatin, or ifosfamide have a high prevalence of late kidney abnormalities. Research must elucidate best practice for post-cancer treatment follow-up and kidney complication treatment.
BACKGROUND: Childhood cancer survivors treated with cisplatin, ifosfamide, or carboplatin are at risk for late kidney and blood pressure (BP) abnormalities. Few studies have comprehensively evaluated kidney outcomes and 24-h ambulatory BP monitoring (ABPM) in this population. We aimed to describe chemotherapy-associated acute kidney injury (AKI) and late kidney outcomes using standardized definitions. METHODS: This was a single-center longitudinal pilot study of 23 children who participated in a previous study during cisplatin, carboplatin, or ifosfamide treatment. Medical charts were reviewed retrospectively. Available patients were approached for a study visit for blood and urine collection, BP measurement, and ABPM. AKI is defined by serum creatinine (SCr) rise (Kidney Disease: Improving Global Outcomes definition [SCr-AKI]). Electrolyte-AKI is defined by hypokalemia, hypophosphatemia, or hypomagnesemia. Chronic kidney disease (CKD) is defined by estimated glomerular filtration rate < 90 mL/min/1.73 m2, albuminuria, or proteinuria. Electrolyte-CKD is defined by low serum electrolyte concentration or electrolyte supplementation. RESULTS: Median age at chemotherapy start was 8.3 years; 9/23 (39%) were boys. Fourteen out of 23 (61%) patients had SCr-AKI during therapy; all developed electrolyte-AKI. Median 5.7 years post-chemotherapy, 7/22 (32%) had CKD, 11/23 (48%) had electrolyte-CKD, and 2/20 (10%) had hypertension. Fifteen out of 23 patients (65%) had either CKD, electrolyte-CKD, or hypertension. In ten patients available for a study visit (median 4.9 years post-chemotherapy), 1/10 (10%) had hypertension by ABPM; none had masked or white coat hypertension. All ten had at least one kidney abnormality (CKD, electrolyte-CKD, office pre-hypertension, or abnormal ABPM). CONCLUSIONS: Using standardized outcome definitions, children treated with cisplatin, carboplatin, or ifosfamide have a high prevalence of late kidney abnormalities. Research must elucidate best practice for post-cancer treatment follow-up and kidney complication treatment.
Authors: Sebastiaan L Knijnenburg; Monique W Jaspers; Helena J van der Pal; Antoinette Y Schouten-van Meeteren; Antonia H Bouts; Jan A Lieverst; Arend Bökenkamp; Caro C E Koning; Foppe Oldenburger; James C H Wilde; Flora E van Leeuwen; Huib N Caron; Leontien C Kremer Journal: Clin J Am Soc Nephrol Date: 2012-07-19 Impact factor: 8.237
Authors: Siobhan M Phillips; Lynne S Padgett; Wendy M Leisenring; Kayla K Stratton; Ken Bishop; Kevin R Krull; Catherine M Alfano; Todd M Gibson; Janet S de Moor; Danielle Blanch Hartigan; Gregory T Armstrong; Leslie L Robison; Julia H Rowland; Kevin C Oeffinger; Angela B Mariotto Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-04 Impact factor: 4.254
Authors: Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella Journal: Circulation Date: 2005-02-08 Impact factor: 29.690
Authors: Roderick Skinner; Annie Parry; Lisa Price; Michael Cole; Alan W Craft; Andrew D J Pearson Journal: Eur J Cancer Date: 2009-10-21 Impact factor: 9.162
Authors: Sebastiaan L Knijnenburg; Renée L Mulder; Antoinette Y N Schouten-Van Meeteren; Arend Bökenkamp; Hester Blufpand; Eline van Dulmen-den Broeder; Margreet A Veening; Leontien C M Kremer; Monique W M Jaspers Journal: Cochrane Database Syst Rev Date: 2013-10-08
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Anke H Maitland-van der Zee; Bruce C Carleton; Zulfan Zazuli; Catharina J P Op 't Hoog; Susanne J H Vijverberg; Rosalinde Masereeuw; Shahrad Rod Rassekh; Mara Medeiros; Rodolfo Rivas-Ruiz Journal: Pediatr Nephrol Date: 2022-06-24 Impact factor: 3.714
Authors: Kelly R McMahon; Hayton Chui; Shahrad Rod Rassekh; Kirk R Schultz; Tom D Blydt-Hansen; Cherry Mammen; Maury Pinsk; Geoffrey D E Cuvelier; Bruce C Carleton; Ross T Tsuyuki; Colin J D Ross; Prasad Devarajan; Louis Huynh; Mariya Yordanova; Frédérik Crépeau-Hubert; Stella Wang; Vedran Cockovski; Ana Palijan; Michael Zappitelli Journal: Kidney360 Date: 2021-11-03
Authors: Sophia M Sears; Joanna L Feng; Andrew Orwick; Alexis A Vega; Austin M Krueger; Parag P Shah; Mark A Doll; Levi J Beverly; Leah J Siskind Journal: Am J Physiol Renal Physiol Date: 2022-07-07
Authors: Bryan V Dieffenbach; Qi Liu; Andrew J Murphy; Deborah R Stein; Natalie Wu; Arin L Madenci; Wendy M Leisenring; Nina S Kadan-Lottick; Emily R Christison-Lagay; Robert E Goldsby; Rebecca M Howell; Susan A Smith; Kevin C Oeffinger; Yutaka Yasui; Gregory T Armstrong; Christopher B Weldon; Eric J Chow; Brent R Weil Journal: Eur J Cancer Date: 2021-08-11 Impact factor: 10.002
Authors: Anna Menshikh; Lauren Scarfe; Rachel Delgado; Charlene Finney; Yuantee Zhu; Haichun Yang; Mark P de Caestecker Journal: Am J Physiol Renal Physiol Date: 2019-09-11